Kodiak Sciences to Host Investor R&D Day Today at 10:30am Eastern Time

Rhea-AI Summary

Kodiak Sciences (Nasdaq: KOD) is hosting its Investor R&D Day today in New York from 10:30 am to 12:30 pm ET. The event can be accessed virtually and will feature presentations from Kodiak's leadership team and leading retina specialist key opinion leaders. The agenda includes discussions on the science of durability, enhanced formulation, clinical program overview, and the Kodiak opportunity.

Speakers include David Brown, MD, Clinical Professor of Ophthalmology at Baylor College of Medicine, and Charles Wykoff, MD, PhD, Clinical Professor of Ophthalmology at Weill Cornell Medical College. The event will also preview Kodiak's ABCD Platform and conclude with a summary and audience Q&A session.

A live webcast, replay, and presentation slides will be available on Kodiak's Investors & Media website. This event provides an opportunity for investors to gain insights into Kodiak's research and development efforts in the field of ophthalmology.

NEW YORK, Sept. 23, 2024 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), will host its Investor R&D Day today in New York. The event is from 10:30 am ET to 12:30 pm ET and can be accessed virtually at https://edge.media-server.com/mmc/p/2ff5vrm7.

A link to the live webcast, replay and presentation slides of the event will be available on the "Events and Presentations" section of Kodiak's Investors & Media website at http://ir.kodiak.com/. A replay of the webcast will be available for a limited time following the event.

The event will feature speakers from members of the Kodiak leadership team and the following leading retina specialist key opinion leaders (KOLs):

• David Brown, MD, Clinical Professor of Ophthalmology, Baylor College of Medicine; Director of Research, Retina Consultants of Texas, Houston, TX; Chair, Medical Leadership Board, Retina Consultants of America
  
  
• Charles Wykoff, MD, PhD, Clinical Professor of Ophthalmology Weill Cornell Medical College, Houston Methodist Hospital; Clinical Professor of Ophthalmology, Blanton Eye Institute; Director of Research, Retina Consultants of Texas; Deputy Chair of Ophthalmology, Blanton Eye Institute

Kodiak's Investor R&D Day Agenda

• Why Kodiak
  Victor Perlroth, M.D.
  
  
• Science of Durability
  David Brown, M.D.
  
  
• Science of the Enhanced Formulation
  David Brown, M.D.
  
  
• Roundtable Discussion
  
  
• Clinical Program Overview
  Charles Wykoff, M.D., Ph.D.
  
  
• The Kodiak Opportunity
  Victor Perlroth, M.D.
  
  
• Roundtable Discussion
  
  
• ABCD Platform Preview
  Dolly Chang, M.D., Ph.D.
  
  
• Summary and Takeaways
  Victor Perlroth, M.D.
  
  
• Audience Q&A

About Kodiak Sciences Inc.

Kodiak Sciences (Nasdaq: KOD) is a biopharmaceutical company committed to researching, developing, and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases. We are focused on bringing new science to the design and manufacture of next generation retinal medicines to prevent and treat the leading causes of blindness globally.

For more information, please visit www.kodiak.com.

Kodiak®, Kodiak Sciences®, ABC™, ABC Platform™ and the Kodiak logo are registered trademarks or trademarks of Kodiak Sciences Inc. in various global jurisdictions.

View original content:https://www.prnewswire.com/news-releases/kodiak-sciences-to-host-investor-rd-day-today-at-1030am-eastern-time-302254951.html

SOURCE Kodiak Sciences Inc.

FAQ

When and where is Kodiak Sciences (KOD) hosting its Investor R&D Day?

Kodiak Sciences (KOD) is hosting its Investor R&D Day on September 23, 2024, in New York from 10:30 am to 12:30 pm ET. The event can also be accessed virtually.

Who are the key speakers at Kodiak Sciences' (KOD) Investor R&D Day?

The key speakers include David Brown, MD, Clinical Professor of Ophthalmology at Baylor College of Medicine, and Charles Wykoff, MD, PhD, Clinical Professor of Ophthalmology at Weill Cornell Medical College, along with members of Kodiak's leadership team.

What topics will be covered during Kodiak Sciences' (KOD) Investor R&D Day?

The event will cover topics such as the science of durability, enhanced formulation, clinical program overview, the Kodiak opportunity, and a preview of the ABCD Platform. It will also include roundtable discussions and an audience Q&A session.

How can investors access Kodiak Sciences' (KOD) Investor R&D Day?

Investors can access the event virtually through a live webcast. The link to the webcast, replay, and presentation slides will be available on the 'Events and Presentations' section of Kodiak's Investors & Media website at http://ir.kodiak.com/.